3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
126
Gastrointestinal
59
Genitourinary
36
Thoracic
30
Other hematologic neoplasm
25
Lymphoid
25
Other
22
Gynecologic
15
Tumor-Agnostic
14
Plasma cell
10
Head & Neck
10
CNS
8
Endocrine
4
Dermatologic
3
Sarcoma
2
Other solid neoplasm
2
Myeloid
2
Other neoplasm
1
Classical hematology
1
Conditions
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Cytopenia
1
Interventions
Cyclophosphamide
21
fludarabine phosphate
15
Cyclosporine
13
Antilymphocyte Serum
13
Peripheral Blood Stem Cell Transplantation
12
Busulfan
12
Whole-Body Irradiation
11
Mycophenolic Acid
10
Filgrastim
8
fludarabine
7
Methotrexate
7
Melphalan
7
Therapeutics
5
Radiotherapy
5
Cytarabine
5
Blood Specimen Collection
5
Tacrolimus
4
Psychiatric Rehabilitation
4
Methylprednisolone
4
Cord Blood Stem Cell Transplantation
4
thymoglobulin
3
Stem Cell Transplantation
3
Palliative Care
3
Imatinib Mesylate
3
Granulocyte Colony-Stimulating Factor
3
Flow Cytometry
3
Dexamethasone
3
Behavior Therapy
3
Aprepitant
3
sargramostim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Exercise
×
Myeloid
×
Clear all
NCT07384039
2026-02-05
MPN-Exercise
Hannover Medical School
Phase NA
Not yet recruiting
80 enrolled
NCT06773871
2025-08-19
HemEx
Rigshospitalet, Denmark
Phase NA
Recruiting
36 enrolled